Cargando…

Peripheral Blood Markers Associated with Immune-Related Adverse Effects in Patients Who Had Advanced Non-Small Cell Lung Cancer Treated with PD-1 Inhibitors

BACKGROUND: Immune checkpoint inhibitors (ICIs) have transformed the treatment landscape for patients with advanced non-small-cell lung cancer (aNSCLC), but immune-related adverse events (irAEs) have been evidenced curtailed the clinical use of them. PURPOSE: The aim of this study was to research th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Wenhui, Liu, Yiping, Ma, Fang, Sun, Bao, Wang, Ying, Luo, Jianquan, Liu, Mouze, Luo, Zhiying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850423/ https://www.ncbi.nlm.nih.gov/pubmed/33536784 http://dx.doi.org/10.2147/CMAR.S293200

Ejemplares similares

Intestinal Microbiome Associated With Immune-Related Adverse Events for Patients Treated With Anti-PD-1 Inhibitors, a Real-World Study
por: Liu, Wenhui, et al.
Publicado: (2021)

Pleiotropic Effects of Metformin on the Antitumor Efficiency of Immune Checkpoint Inhibitors
por: Liu, Wenhui, et al.
Publicado: (2021)

Integrated analysis of clinical and genetic factors on the interindividual variation of warfarin anticoagulation efficacy in clinical practice
por: Sun, Bao, et al.
Publicado: (2023)

Vitamin D metabolism pathway polymorphisms are associated with efficacy and safety in patients under anti-PD-1 inhibitor therapy
por: Luo, Jianquan, et al.
Publicado: (2022)

Current landscape and tailored management of immune-related adverse events
por: Liu, Wenhui, et al.
Publicado: (2023)

Peripheral blood markers predictive of outcome and immune-related adverse events in advanced non-small cell lung cancer treated with PD-1 inhibitors
por: Peng, Lihong, et al.
Publicado: (2020)

Durvalumab-Induced Demyelinating Lesions in a Patient With Extensive-Stage Small-Cell Lung Cancer: A Case Report
por: Liu, Wenhui, et al.
Publicado: (2022)

Genetic Polymorphisms and Platinum-Based Chemotherapy-Induced Toxicities in Patients With Lung Cancer: A Systematic Review and Meta-Analysis
por: Liu, Wenhui, et al.
Publicado: (2020)

Inflammation‐nutritional markers of peripheral blood could predict survival in advanced non‐small‐cell lung cancer patients treated with PD‐1 inhibitors
por: Pu, Dan, et al.
Publicado: (2021)

Association between Early Immune-Related Adverse Events and Survival in Patients Treated with PD-1/PD-L1 Inhibitors
por: Zhang, You-Cheng, et al.
Publicado: (2023)

Absolute eosinophil count may be an optimal peripheral blood marker to identify the risk of immune-related adverse events in advanced malignant tumors treated with PD-1/PD-L1 inhibitors: a retrospective analysis
por: Ma, Yan, et al.
Publicado: (2022)

Central and Peripheral Adiposity Had Different Effect on Disability in Centenarians
por: Yang, Shanshan, et al.
Publicado: (2021)

Characteristics of Immune-Related Thyroid Adverse Events in Patients Treated with PD-1/PD-L1 Inhibitors
por: Yoon, Jee Hee, et al.
Publicado: (2021)

Patients with melanoma treated with immune checkpoint inhibitors who had non-thyroid endocrine and skin immune-related adverse events have better prognosis: A systematic review and meta-analysis
por: Sun, Qian, et al.
Publicado: (2022)

Results of Observations on Small-pox in Persons Who Had Been Vaccinated
Publicado: (1845)

Gut Microbiota and Antidiabetic Drugs: Perspectives of Personalized Treatment in Type 2 Diabetes Mellitus
por: Liu, Wenhui, et al.
Publicado: (2022)

A Case with Hyperthyroidism Who Had Been Treated with Thyroid Hormone Because of Congenital Hypothyroidism
por: Otsubo, Kiyoko, et al.
Publicado: (2005)

Hepatic angiosarcoma in an adult who had Wilms tumor treated in childhood: A case report
por: Shayesteh, Shahab, et al.
Publicado: (2020)

Treatment of immune thrombocytopenia with eltrombopag in patients who had and who had not received prior rituximab: post‐hoc analysis of the EXTEND study
por: Meyer, Oliver, et al.
Publicado: (2021)

Ocular adverse events in PD-1 and PD-L1 inhibitors
por: Young, LeAnne, et al.
Publicado: (2021)

Changes in expression of PD-L1 on peripheral T cells in patients with melanoma and lung cancer treated with PD-1 inhibitors
por: Dart, Sarah J., et al.
Publicado: (2021)

Pulmonary adverse events associated with hypertension in non-small cell lung cancer patients receiving PD-1/PD-L1 inhibitors
por: Chen, Jianing, et al.
Publicado: (2022)

Assessment of Human Tribbles Homolog 3 Genetic Variation (rs2295490) Effects on Type 2 Diabetes Patients with Glucose Control and Blood Pressure Lowering Treatment
por: He, Fazhong, et al.
Publicado: (2016)

Corrigendum to “Assessment of Human Tribbles Homolog 3 Genetic Variation (rs2295490) Effects on Type 2 Diabetes Patients with Glucose Control and Blood Pressure Lowering Treatment” [EBioMedicine 13 (2016) 181–189]
por: He, Fazhong, et al.
Publicado: (2017)

Case Report: Immunotherapy for low-grade myofibroblastic sarcoma of the pharynx
por: Sun, Bao, et al.
Publicado: (2023)

Supportive care needs of patients who had a stroke: a scoping review protocol
por: Zhang, Huimin, et al.
Publicado: (2023)

Association of Immune-Related Adverse Effects and Survival in Solid Tumor Patients Treated with PD1 Inhibitors
por: Kapoor, Akhil, et al.
Publicado: (2022)

The views and perceptions of water immersion for labor and birth from women who had birthed in Australia but had not used the option
por: Cooper, Megan, et al.
Publicado: (2022)

Experience of an English Dentist Who Had Two Teeth Implanted
por: Gartrell, J. H.
Publicado: (1887)

Turquoise Urine in a Man Who Had Urinary Retention
por: Lucerna, Alan, et al.
Publicado: (2023)

Treatment of patients with cancer using PD-1/PD-L1 antibodies: Adverse effects and management strategies (Review)
por: Sun, Guangshun, et al.
Publicado: (2022)

Apatinib in treating patients with recurrent or metastatic nasopharyngeal carcinoma who had failed prior platinum-based chemotherapy
por: Tao, Chang-Juan, et al.
Publicado: (2020)

Account of a Woman Who Had the Small Pox during Pregnancy, and Who Communicated the Same Disease to Her Fœtus
Publicado: (1781)

Questionnaire-based detection of immune-related adverse events in cancer patients treated with PD-1/PD-L1 immune checkpoint inhibitors
por: Griewing, Luisa Maria, et al.
Publicado: (2021)

Incidence and characteristics of adverse drug reactions in a cohort of patients treated with PD-1/PD-L1 inhibitors in real-world practice
por: Sabaté Gallego, Mònica, et al.
Publicado: (2022)

PD0325901, an ERK inhibitor, enhances the efficacy of PD-1 inhibitor in non-small cell lung carcinoma
por: Luo, Min, et al.
Publicado: (2021)

Next-generation sequencing revealed influenza and Chlamydia infection in recurrent pneumonia in a patient who had recovered from COVID-19
por: Wen, Wen, et al.
Publicado: (2020)

Slow-Release H(2)S Donor Anethole Dithiolethione Protects Liver From Lipotoxicity by Improving Fatty Acid Metabolism
por: Zhao, Chengcheng, et al.
Publicado: (2020)

Psychological impact in non-infectious disease specialists who had direct contact with patients with COVID-19
por: Liu, Tao, et al.
Publicado: (2020)

Neurological adverse events associated with PD-1/PD-L1 immune checkpoint inhibitors
por: Zhou, Yanting, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_l6pohh0n5sshh13nukhuovf1ee